Our focus was on the modulation of these pathways in response to T cell activation, with a particular emphasis on the enrichment of pathways such as NF-κB and primary immunodeficiency signaling, as well as ubiquitin-mediated proteolysis. This evidence concerns the gene NFKB1 and inborn error of immunity.